Navigation Links
Hemispherx Presents Evidence of Ampligen Synergies with Existing,Antivirals at International Avian Influenza Conference

PARIS--(BUSINESS WIRE)--Jun 4, 2007 - Hemispherx Biopharma, Inc. (AMEX: HEB), a biopharmaceutical company engaged in the clinical development of new drug entities for the treatment of pandemic disease threats, announced today a new scientific report on the activity of its experimental therapeutic Ampligen(R) in combination with approved anti-influenza agents against highly pathogenic avian influenza (HPAI), also known as bird flu.

Tamiflu resistance by newly emerging strains of HPAI has been widely reported (New Engl. Journal Medicine vol. 353: page 2667, 2005) and has provided impetus for new ways to implement an antiviral counter-attack strategy.

In in vitro studies, Ampligen(R), an experimental therapeutic, was combined with the neuraminidase inhibitors Oseltamivir, (brand name Tamiflu) and with Zanamivir (Relenza) and thereafter applied to cells in culture infected with an H5N1 strain of HPAI. Three days following infection, cell viability and synergy analyses were performed.

Both Ampligen(R) and the neuraminidase inhibitors exhibited dose responses in the inhibition of the adverse effects of HPAI on cell cultures. Moreover, the combination of Ampligen(R) with oseltamivir at doses exceeding a certain threshold showed synergistic inhibition of viral induced cell destruction, and similar synergistic results were seen with the combination of Ampligen(R) with zanamivir.

The study results are being presented at the ongoing 2nd International Conference on Avian Influenza, being held at the Pasteur Institute.

While it is widely recognized that HPAI is a major, global public health concern, existing antiviral monotherapies can rapidly lead to drug-resistant strains of virus. Therefore, the Hemispherx study was conducted to establish a potentially pivotal role for Ampligen as part of a potentially effective combination therapy. Ampligen(R) is a novel double-stranded RNA experimental thera
'"/>




Page: 1 2 3

Related medicine technology :

1. Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:7/7/2015)... , July 01, 2015 ... announced the addition of the "Elemental Analysis ... ICP-MS), Nondestructive (XRD, OES)), Application (Life Sciences, Food ... Global Forecasts to 2020" report to their ... on the basis of types, technologies, and applications. ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the ... to their offering. This patent ... Photoacoustic imaging is a safe, non-invasive, non-ionizing ... and represents a great alternative to traditional ...
(Date:7/7/2015)... , July 7, 2015 Sequent Medical, ... developing innovative devices for the treatment of neurovascular ... has joined its Board of Directors.   ... of medical device and healthcare industries experience.  He ... he has commercialized numerous leading-edge products.  His experience ...
Breaking Medicine Technology:Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
... SAN DIEGO, March 20, 2012  HUYA Bioscience International ... of China,s preeminent pharmacological researchers, Prof. Deyong Ye ... an international leader in supporting the global development ... Fudan University will focus on specific innovations coming ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Ibandronate Sodium Tablets, 150mg. This product is the generic ... treatment and prevention of osteoporosis in postmenopausal women. ...
Cached Medicine Technology:HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 2HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 3
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Difass USA, ... can help pass those long, stressful days at work is knowing that there is ... as laid back and stress free as imagined. Planning for a vacation can be ...
(Date:7/7/2015)... ... July 07, 2015 , ... Seattle-based ... have merged to form Camber Collective. Camber Collective provides strategic advisory services ... SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in customer insights, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Quadrino Law Group is pleased ... 304, Melville, New York 11747. The new facility is a state of the ... lines. , Richard Quadrino, the firm's CEO and founder, said, "We are pleased to ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in ... . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce ... On this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper ...
(Date:7/7/2015)... ... 2015 , ... Healthpointe is proud to announce the addition of ... pain management specialist, will be evaluating and treating patients with orthopedic complaints, such as ... his Bachelor of Science in Biology from the University of the East, Manila, Dr. ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... September 3 (HealthDay News) -- A 7-year-old San Diego boy brought ... Switzerland a couple years ago. While there, he became infected ... him vaccinated against. Upon his return to the United States, the ... a true tale -- is the type of nightmare scenario that ...
... study aimed at improving the care of muscular ... physical therapists, and researchers at the University of ... M.D., is heading the study of treatments for ... the disease that affects children. The condition, which ...
... , THURSDAY, Sept. 2 (HealthDay News) -- Many Americans ... often believing they are thinner than they really are, ... poll finds. As part of the Harris Interactive/HealthDay ... weight, from which pollsters calculated their body-mass index (BMI), ...
... , DURHAM, N.C. Millions of patients with advanced disease ... breathe more easily. But a new study from Duke ... from the intervention, and among those who do benefit, it ... oxygen or just plain old room air both offer ...
... COLUMBUS, Ohio There is yet no straightforward way ... for high-dose radiation therapies such as stereotactic radiation therapy, ... high-dose brachytherapy for prostate and other cancers., Radiation oncologists ... James Cancer Hospital and Richard J. Solove Research Institute ...
... HealthDay Reporter , THURSDAY, Sept. 2 (HealthDay News) ... about the young, possibly because it makes them feel ... time they spent with negative news about young people, ... self-esteem boost out of this," said study author Silvia ...
Cached Medicine News:Health News:Disease May Be Only a Plane Ride Away 2Health News:Disease May Be Only a Plane Ride Away 3Health News:Rochester leads international effort to improve muscular dystrophy treatment 2Health News:Rochester leads international effort to improve muscular dystrophy treatment 3Health News:Rochester leads international effort to improve muscular dystrophy treatment 4Health News:Many Americans Don't Even Know They're Fat 2Health News:Many Americans Don't Even Know They're Fat 3Health News:Study challenges value of oxygen therapy in end-of-life care 2Health News:Study challenges value of oxygen therapy in end-of-life care 3Health News:New model may simplify high-dose radiosurgery planning 2Health News:Seniors Get Boost From Bad News About the Young 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: